BELLEVUE, Wash., Sept. 11, 2019 /PRNewswire/ -- Innovega Inc.
announced and described the experimental proof of their technology
for managing the primary accepted cause of eye discomfort and
visual fatigue when using Virtual and Augmented Reality displays.
The results of the experiment support the ability of the iOptik®
contact lens when used with Innovega eyewear to deliver the
required depth of field to eliminate the offending
vergence-accommodation conflict. Innovega Director of
Opto-electronics and Photonics Mark
Freeman, PhD and Vice President of Engineering Jay Marsh, MSME have published an update to
their white paper to provide the methods, results, and
conclusions.
Dr. Freeman commented, "The new video that we've included gives
a quantifiable measure of acuity and depth of field using the
iOptik® smart contact lens. Unlike the optics used in competing
eyewear, the long depth of field and accommodation invariance of
Innovega's technology can remove the discomfort associated with
viewing 3D AR and VR displays. The wearer of Innovega lenses and
eyewear will be able to verge their eyes to any distance needed to
fuse the stereo content into a 3D image, and their eyes can focus
to this same depth as is natural and comfortable. Display content
remains in focus independent of the depth at which the wearer is
focusing."
Co-author Jay Marsh added, "We
are pleased to demonstrate the extended depth of field of our
contact lens-enabled eyewear. This proves that Innovega's contact
lens technology keeps the display in focus over the full depth
range needed for 3D AR and VR platforms."
"This feature eliminates a major challenge faced by developers
of augmented and virtual reality eyewear. We have proved that our
next generation contact lenses will deliver content that is always
in focus without relying on the management of multiple display
planes or active refocusing," said Steve
Willey, Innovega Co-Founder, President and CEO. Willey
added, "We look forward to delivering this valuable benefit to our
prospective partners, along with application and content
developers."
About Innovega
Innovega Inc. is developing stylish,
lightweight, wearable displays that feature a high-resolution,
panoramic-field-of-view system for medical, consumer, and
industrial application. The Company is licensing its technology
into the $74
billion global vision care market with a focus on image
enhancement for the visually impaired. Its transformative patented
platform, eMacula™, includes eyewear and iOptik® high-resolution
smart contact lenses that work together to deliver broad
application in medicine, augmented reality (AR), and virtual
reality (VR). The Company has been supported by the Defense
Advanced Research Projects Agency (DARPA), National Eye Institute
(NEI) of National Institutes of Health (NIH), and National Science
Foundation (NSF) and has received investments from strategic
partners. The iOptik contact lens is in the FDA De Novo process
Phase II clinical trials in progress. The Company is also pursuing
FDA 510(k) Clearance for its lens material.
Media Inquiries
Stephen
Willey
Email: 221579@email4pr.com
Cell: 425 516 8175
View original
content:http://www.prnewswire.com/news-releases/innovega-provides-experimental-proof-of-augmented-and-virtual-reality-eyestrain-management-technology-300915466.html
SOURCE Innovega Inc.